洪超,博士,副教授,硕士生导师
基本信息
电子邮箱:shutcmhong@163.com
通讯地址:上海市浦东新区蔡伦路1200号
招生专业
研究方向:中药药剂
院系名称:中药学院
学位类型:学术学位
专业名称:中药学/100800
2008.09-2012.07, 中国药科大学, 制药工程, 学士
2012.09-2015.07, 上海中医药大学, 中药学, 硕士
2015.09-2019.07, 复旦大学, 药剂学, 博士
任职经历
2019.08-2021.07, 美国俄亥俄州立大学 The Ohio State University, 博士后研究员
2021.08-2023.07, 上海中医药大学, 教学实验中心, 副教授
2023.08-至 今, 上海中医药大学, 中药学院, 副教授
承担科研项目情况
上海市自然基金面上项目,基于中医“扶正固本”和高效联合循环式靶向递送免疫药物组合的多功能脂质体的构建与评价,主持
上海市人力资源和社会保障局“上海市白玉兰计划(青年项目)”,主持
上海市地方高水平大学建设引进人才科研经费,主持
国家自然科学基金面上项目,重楼皂苷调控胆固醇稳态失衡抑制ABCB1和EGFR克服肝癌获得性耐药的作用机制研究,参与
主要代表性成果
Hong C#, WangAN#, XiaJX, et al. Ginsenoside Rh2-based multifunctional liposomes for advanced breast cancer therapy. Int J Nanomed. (Accept) (IF = 8)
Jiang M#, Chen LX#, Hong C#, et al. A novel polyphyllin I-based liposome delivery system sensitizes hepatic carcinoma to doxorubicin via cholesterol modulation. J Drug Deliv Sci Tec. 2022,78: 103925. (IF = 5)
Hong C, Liang JM, Guo YZ, et al. One stone four birds—a ginsenoside Rh2 based multifunctional liposome for tumor targeting therapy. Nano-Micro Lett. 2020, 12: 129. (IF 26.6)
Hong C, Wang D, Liang JM, et al. Novel ginsenoside based multifunctional liposomal delivery system for combination gastric cancer therapy. Theranostics. 2019, 9: 4437. (IF 12.4)
Hong C, Yang P, Li SP, et al. In vitro/in vivo metabolism of ginsenoside Rg5 in rat using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Molecules. 2018, 23:2113. (IF 4.6)
Hong C, Wang JX. Comparison of pharmaceutical quality of eight generic ganciclovir injections in China and Cymevene. J Chemotherapy. 2018, 30:310-315. (IF 1.8)
Liu MY#, Hong C#, Li GW, et al. The generation of myricetin-nicotinamide nanococrystals by top down and bottom up technologies. Nanotechnology. 2016, 27(39):395-601. (IF 3.5)
Hong C, Xie Y, Yao Y, et al. A Novel Strategy for Pharmaceutical Cocrystal Generation without Knowledge of Stoichiometric Ratio: Myricetin Cocrystals and a Ternary Phase Diagram. Pharm Res. 2015, 32:47-60. (IF 3.7)
Hong C, Dang Y, Lin G, et al. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. Int J Pharm. 2014, 477:251-260. (IF 5.8)